Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Association of Short Antenatal Corticosteroid Administration-to-Birth Intervals With Survival and Morbidity Among Very Preterm Infants: Results From the EPICE Cohort

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Prenatal Vitamin D Supplementation to Improve Health in Offspring

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effect of Needle Aspiration of Pneumothorax on Subsequent Chest Drain Insertion in Newborns: A Randomized Clinical Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Association Between the Safe Delivery App and Quality of Care and Perinatal Survival in Ethiopia: A Randomized Clinical Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Infant Growth and Risk of Childhood-Onset Type 1 Diabetes in Children From 2 Scandinavian Birth Cohorts

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Akutte alvorlige sygdomme hos gravide og fødende

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiUndervisningpeer review

  2. Bacille Calmette-Guérin vaccination at birth and differential white blood cell count in infancy. A randomised clinical trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Characteristics, management and outcomes of very preterm triplets in 19 European regions

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Breastfeeding outcomes in European NICUs: impact of parental visiting policies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Mikael Norman
  • Aurelie Piedvache
  • Klaus Børch
  • Lene Drasbek Huusom
  • Anna-Karin Edstedt Bonamy
  • Elizabeth A Howell
  • Pierre-Henri Jarreau
  • Rolf F Maier
  • Ole Pryds
  • Liis Toome
  • Heili Varendi
  • Tom Weber
  • Emilija Wilson
  • Arno van Heijst
  • Marina Cuttini
  • Jan Mazela
  • Henrique Barros
  • Patrick Van Reempts
  • Elizabeth S Draper
  • Jennifer Zeitlin
  • Effective Perinatal Intensive Care in Europe (EPICE) Research Group
Vis graf over relationer

Importance: Administration-to-birth intervals of antenatal corticosteroids (ANS) vary. The significance of this variation is unclear. Specifically, to our knowledge, the shortest effective administration-to-birth interval is unknown.

Objective: To explore the associations between ANS administration-to-birth interval and survival and morbidity among very preterm infants.

Design, Setting, and Participants: The Effective Perinatal Intensive Care in Europe (EPICE) study, a population-based prospective cohort study, gathered data from 19 regions in 11 European countries in 2011 and 2012 on 4594 singleton infants with gestational ages between 24 and 31 weeks, without severe anomalies and unexposed to repeated courses of ANS. Data were analyzed November 2016.

Exposure: Time from first injection of ANS to delivery in hours and days.

Main Outcomes and Measures: Three outcomes were studied: in-hospital mortality; a composite of mortality or severe neonatal morbidity, defined as an intraventricular hemorrhage grade of 3 or greater, cystic periventricular leukomalacia, surgical necrotizing enterocolitis, or stage 3 or greater retinopathy of prematurity; and severe neonatal brain injury, defined as an intraventricular hemorrhage grade of 3 or greater or cystic periventricular leukomalacia.

Results: Of the 4594 infants included in the cohort, 2496 infants (54.3%) were boys, and the mean (SD) gestational age was 28.5 (2.2) weeks and mean (SD) birth weight was 1213 (400) g. Mortality for the 662 infants (14.4%) unexposed to ANS was 20.6% (136 of 661). Administration of ANS was associated with an immediate and rapid decline in mortality, reaching a plateau with more than 50% risk reduction after an administration-to-birth interval of 18 to 36 hours. A similar pattern for timing was seen for the composite mortality or morbidity outcome, whereas a significant risk reduction of severe neonatal brain injury was associated with longer administration-to-birth intervals (greater than 48 hours). For all outcomes, the risk reduction associated with ANS was transient, with increasing mortality and risk for severe neonatal brain injury associated with administration-to-birth intervals exceeding 1 week. Under the assumption of a causal relationship between timing of ANS and mortality, a simulation of ANS administered 3 hours before delivery to infants who did not receive ANS showed that their estimated decline in mortality would be 26%.

Conclusions and Relevance: Antenatal corticosteroids may be effective even if given only hours before delivery. Therefore, the infants of pregnant women at risk of imminent preterm delivery may benefit from its use.

OriginalsprogEngelsk
TidsskriftJAMA Pediatrics
Vol/bind171
Udgave nummer7
Sider (fra-til)678-686
ISSN2168-6203
DOI
StatusUdgivet - 1 jul. 2017

ID: 50563489